{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT02516150","recordId":"NCT02516150","peptideSlug":"glucagon","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct02516150-glucagon/","json":"https://peptidescanner.com/clinical-trials-history/v1/trials/nct02516150.json","markdown":"https://peptidescanner.com/clinical-trials-history/v1/trials/nct02516150.md"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2015-08-03","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"glucagon","submittedDate":"2015-08-03","publishedAt":"2026-08-23","recordId":"NCT02516150","recordSha256":"4446c92c5169296adea666054d45a99360ba9b8ba82eac8184eed6f1dff28a6c","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02516150?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2016-03-15","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"glucagon","submittedDate":"2016-03-15","publishedAt":"2026-08-23","recordId":"NCT02516150","recordSha256":"a4f52c40dcc4a06f26ca50b00f22f74595640f88c09068e96fedc5763e6ec836","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02516150?a=2&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Arms and Interventions","Contacts/Locations","Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2016-05-16","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"glucagon","submittedDate":"2016-05-16","publishedAt":"2026-08-23","recordId":"NCT02516150","recordSha256":"4b35168de6e04fc86bda5927b501ff3c4f8a19464b123d04d9f90551b83c53ed","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02516150?a=3&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":4,"lastUpdateSubmitQcDate":"2016-09-06","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"glucagon","submittedDate":"2016-09-06","publishedAt":"2026-08-23","recordId":"NCT02516150","recordSha256":"d71a9b0630e2051339a92652b3407d5df488f0f231afb7f488f90afd9762097c","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02516150?a=4&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Design","Study Status"],"historyVersion":5,"lastUpdateSubmitQcDate":"2017-02-06","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"glucagon","submittedDate":"2017-02-06","publishedAt":"2026-08-23","recordId":"NCT02516150","recordSha256":"fc9799c106185e82c02ff081cb8a83f3a65cfd5ac285d84e9bdf1390f3804c35","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02516150?a=5&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":6,"lastUpdateSubmitQcDate":"2017-06-27","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"glucagon","submittedDate":"2017-06-27","publishedAt":"2026-08-23","recordId":"NCT02516150","recordSha256":"261fb41ca2b682ea6dda4848bb842ddba9a28efd7f3b34ab0f840e55890bd945","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02516150?a=6&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["IPDSharing","Oversight","Study Design","Study Status"],"historyVersion":7,"lastUpdateSubmitQcDate":"2017-07-06","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"glucagon","submittedDate":"2017-07-06","publishedAt":"2026-08-23","recordId":"NCT02516150","recordSha256":"93a89ebb6db953a9d9468137b1b5c00a950d4b2db9fbd981fe85ecd8a3b481c2","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02516150?a=7&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Adverse Events","Baseline Characteristics","Document Section","More Information","Outcome Measures","Outcome Measures (Results)","Participant Flow","Study Status"],"historyVersion":8,"lastUpdateSubmitQcDate":"2017-07-31","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"glucagon","submittedDate":"2017-07-31","publishedAt":"2026-08-23","recordId":"NCT02516150","recordSha256":"c5302e6afa7f9b9bf4ee442c87a3863f0a76689203e2da16c24490a41cb190b9","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02516150?a=8&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"fc11b3b242c903b959269cc1722515e34e7de303ad2918dbe52a7c9e280922a5"}}